dextrothyroxine has been researched along with Loa loa Filariasis in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.91) | 18.7374 |
1990's | 20 (19.42) | 18.2507 |
2000's | 26 (25.24) | 29.6817 |
2010's | 35 (33.98) | 24.3611 |
2020's | 19 (18.45) | 2.80 |
Authors | Studies |
---|---|
Bikita, P; Boussinesq, M; Campillo, JT; Chesnais, C; Hemilembolo, M; Louya, F; Missamou, F; Pion, SDS | 1 |
Afor, AR; Bamou Heumou, R; Bopda, J; Nana Djeunga, HC; Ntonifor, NH; Ondoua Nganjou, GS; Sumo, L | 1 |
Amoah, B; Atsame, J; Biamonte, M; Diggle, PJ; Ella, SN; Fronterrè, C; Gass, K; Giorgi, E; Hundley, L; Johnson, O; Ogoussan, K | 1 |
Basáñez, MG; Koala, L; Melachio, TT; Thomsen, E; Tirados, I; Worrall, E | 1 |
Andress, BC; Bhagwat, EA; Bryant, CA; Chandrapu, VR; Desmonts, CG; Jacobsen, KH; Matthews, TM; Ogunkoya, A; Wheeler, TJ; Williams, AS | 1 |
Cosano-Palma, E; López-Herrero, F; Montenegro-Quintana, MA; Pérez-García, MV; Sánchez-Vicente, JL; Sotomayor-Toribio, M | 1 |
Ayiseh, RB; Cho-Ngwa, F; Lustigman, S; Mbah, GE; Monya, E; Ndi, EM; Sakanari, J | 1 |
Bouyou-Akotet, MK; Ekomi, B; Mawili-Mboumba, DP; Mourou, JR; Moutombi Ditombi, B; Moutongo Mouandza, R; Roger Sibi Matotou, H | 1 |
Adegnika, AA; Agnandji, ST; Dimessa-Mbadinga-Weyat, LB; Ekoka Mbassi, D; Houtsa-Temgoua, RD; Kresmner, PG; Kreuzmair, R; Lell, B; McCall, MBB; Mischlinger, J; Mombo-Ngoma, G; Ndzebe-Ndoumba, W; Okwu, DG; Ramharter, M; Veletzky, L; Zoleko-Manego, R | 1 |
Boussinesq, M; Chesnais, CB; Deléglise, H; Fletcher, DA; Kamgno, J; Klion, AD; Mackenzie, C; Nana-Djeunga, H; Niamsi-Emalio, Y; Nutman, TB; Pion, SD; Stolk, W | 1 |
Abong, RA; Amuam, A; Dean, L; Ekanya, R; Enyong, P; Forrer, A; Fung, EG; Hamill, L; Kah, E; Khan, JAM; Murdoch, ME; Ndongmo, WPC; Ndzeshang, BL; Niessen, L; Nji, TM; Njouendou, AJ; Njoumemi, Z; Nkimbeng, DA; Nnamdi, DB; Obie, ED; Ozano, K; Piotrowski, H; Taylor, MJ; Teghen, S; Theobald, S; Thomson, R; Turner, JD; Wanji, S; Watson, V; Woode, ME | 1 |
Bouchaud, O; Bourée, P; Cailhol, J; Caumes, E; Dupouy Camet, J; Godineau, N; Loarec, A; Matheron, S; Poilane, I | 1 |
Barro-Traoré, F; Bougma, R; Bougouma, C; Drabo, F; Kaboret, N; Korsaga-Somé, N; Niamba, P; Ouédraogo, M; Ouédraogo, MS; Ouédraogo, NA; Tapsoba, GP; Traoré, A; Traoré, F; Zida, A | 1 |
Agbi, P; Anyaike, C; Davies, E; Emukah, E; Griswold, E; Ityonzughul, C; Kahansim, B; Miri, ES; Nwoke, BEB; Rakers, LJ; Richards, FO | 1 |
Blok, DJ; Boussinesq, M; Chesnais, CB; de Vlas, SJ; Fletcher, DA; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Niamsi-Emalio, Y; Nutman, TB; Pion, SD; Stolk, WA | 1 |
Babiker, A; Bhamidipati, D; Burd, EM; Fairley, JK; Mathison, BA; Woc-Colburn, LE | 1 |
Basáñez, MG; Boussinesq, M; Chesnais, CB; Kamgno, J; Nana-Djeunga, HC; Niamsi-Emalio, Y; Pion, SDS; Tchatchueng-Mbougua, JB | 1 |
Meffert, L; Schmitz, F; Ziob, J | 1 |
Bopda, J; Fay, MP; Gounoue, R; Herrick, JA; Kamgno, J; Klion, AD; Legrand, F; Makiya, M; Metenou, S; Montavon, C; Nchinda, G; Nguluwe, K; Nutman, TB; Ondigui, BE; Tchana, SM | 1 |
Boussinesq, M; Chesnais, CB; Fischer, PU; Missamou, F; Pion, SDS; Weil, GJ | 1 |
Herranz-Aguirre, M; Peñafiel-Freire, DM | 1 |
Agnew, D; Datchoua-Poutcheu, FR; Enyong, P; Esuka, EN; Eversole, RR; Eyong, EJ; Hopkins, A; Kengne-Ouafo, AJ; Mackenzie, CD; Ngwa, CJ; Tendongfor, N; Wanji, S | 1 |
Diop, AG; Mansare, ML; Massi, DG; Ndiaye, M; Ndiaye, MM; Traoré, M | 1 |
Jentes, ES; Lee, D; Montour, J; Snider, C; Stauffer, W | 1 |
Boussinesq, M; Chesnais, CB; Eyebe, S; Kamgno, J; Nana-Djeunga, HC; Pion, SD; Sabbagh, A | 1 |
Bakalar, MH; Boussinesq, M; Chesnais, CB; D'Ambrosio, MV; Fletcher, DA; Gounoue-Kamkumo, R; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Njitchouang, GR; Nutman, TB; Nwane, P; Pion, SD; Stolk, WA; Tchatchueng-Mbouga, JB; Wanji, S | 1 |
Basáñez, MG; Cano, J; O'Hanlon, SJ; Pullan, RL; Rebollo, MP; Tekle, AH; Wanji, S; Zouré, HG | 1 |
Boussinesq, M; Chesnais, CB; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Nutman, TB; Pion, SD | 1 |
Dyson, L; Hollingsworth, TD | 1 |
Bockarie, M; Chounna Ndongmo, WP; Enyong, PA; Fobi, G; Fombad, FF; Kengne-Ouafo, JA; Koudou, B; Longang Tchounkeu, YF; Njouendou, AJ; Roungou, JB; Wanji, S | 1 |
Angheben, A; Bisoffi, Z; Bottieau, E; Bouchaud, O; Buonfrate, D; Calleri, G; Clerinx, J; Gobbi, F; Guerriero, M; Herrera-Ávila, JP; Neumayr, A; Rodari, P; Rojo-Marcos, G; Rothe, C; Salvador, F; Treviño, B; Zammarchi, L | 1 |
Akumtoh, DN; Chounna, PW; Chunda, VC; Fombad, FF; Gandjui, NV; Metuge, HM; Ndzeshang, BL; Njouendou, AJ; Pionnier, NP; Sjoberg, H; Taylor, MJ; Tayong, DB; Turner, JD; Wanji, S | 1 |
Boussinesq, M; Fitzpatrick, C; Fletcher, DA; Kamgno, J; Klion, AD; Lenk, EJ; Moungui, HC; Nana-Djeunga, HC; Niamsi-Emalio, Y; Nutman, TB; Peultier, AMM; Pion, SD; Redekop, WK; Severens, JL; Stolk, WA | 1 |
Boussinesq, M; Coffeng, LE; Pedrique, B; Pion, SDS; Remme, JH; Stolk, WA; Tekle, AH; Vinkeles Melchers, NVS; Wanji, S; Zouré, HGM | 1 |
Angheben, A; Bisoffi, Z; Buonfrate, D; Degani, M; Gobbi, F; Tamarozzi, F | 1 |
Holmes, D | 1 |
Hoerauf, A; Slatko, BE; Taylor, MJ; Townson, S; Ward, SA | 1 |
Boussinesq, M; Demanou, M; Kamgno, J; Kouam, MK; Pion, SD; Tchatchueng-Mbougua, JB | 1 |
Metzger, WG; Mordmüller, B | 1 |
Akame, J; Boussinesq, M; Fokom-Domgue, J; Gounoue, R; Kamgno, J; Nguipdop-Djomo, P; Pion, SD; Thylefors, B; Twum-Danso, NA | 1 |
Bennuru, S; Kamgno, J; Nutman, TB; Pion, SD; Wanji, S | 1 |
Ang, KH; Arkin, M; Bell, A; Bidlow, CM; Bulman, CA; Chen, S; Cho-Ngwa, F; Debnath, A; Franklin, C; Gut, J; Knudsen, GM; Lim, KC; Lustigman, S; Marcellino, C; McKerrow, JH; Rascón, AA; Sakanari, JA; Samje, M; Supakorndej, N; Supakorndej, P; Suzuki, B; Tricoche, N; Williams, D; Wilson, C; Wolfe, AR | 1 |
Adedokun, SA; Adefioye, OA; Adeleke, MA; Adeyeba, OA; Akindele, AA; Akinleye, CA; Bolaji, OS; Ojo, JF; Ojurongbe, O; Oyedeji, MO | 1 |
Boussinesq, M; Chesnais, CB; Paguélé, M; Pion, SD; Takougang, I | 1 |
Adejai, ET; Adeoye, GO; Akinsanya, B; Atalabi, T; Braide, E; Ibidapo, CA; Okeke, P; Otubanjo, OA | 1 |
Adejai, EO; Adeoye, GO; Akinsanya, B; Braide, E; Ibidapo, CA; Okeke, P; Okwuzu, J; Otubanjo, AO | 1 |
Boussinesq, M; Kamgno, J; Mackenzie, CD; Pion, SD | 1 |
Boussinesq, M; Kamgno, J; Mackenzie, CD; Pion, SD; Thylefors, B | 1 |
Enyong, P; Esum, M; Faragher, B; Ford, L; Hoerauf, A; Johnston, KL; Langley, RS; Mand, S; Specht, S; Taylor, MJ; Tendongfor, N; Turner, JD; Wanji, S | 1 |
Amazigo, U; Leak, S; Noma, M; Remme, JH; Tekle, AH; Wanji, S; Zoure, H | 1 |
Bourguinat, C; Boussinesq, M; Geary, TG; Kamgno, J; Mackenzie, CD; Prichard, RK | 1 |
Chani, M; Eljahiri, Y; Iken, M; Mion, G; Nzenze, JR | 1 |
Akinsanya, B; Hassan, AA; Iyase, N; Owagboriaye, FO | 1 |
Baldelli, F; D'Annibale, ML; De Socio, GV; Papili, R; Sgrelli, A | 1 |
Aripko, B; Eka, BL; Enyong, P; Kale, O; Lamlenn, SB; Meli, J; Meremikwu, M; Remme, JH; Takougang, I; Wandji, S; Yenshu, EV | 1 |
Boussinesq, M; Kamgno, J; Moyou-Somo, R; Pion, SD; Tsague-Dongmo, L | 1 |
Meredith, SE; Twum-Danso, NA | 1 |
Bella Hiag, LA; Bengono, G; Fobi, G; McMoli, TE; Moussala, M; Ongolo Zogo, P | 1 |
Remme, JH | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, DS | 1 |
Boussinesq, M; Demanou, M; Oudin, B; Pion, SD | 1 |
Molyneux, DH; Nantulya, V | 1 |
Boussinesq, M; Gardon, J; Kamgno, J; Pion, SD | 1 |
Beck, B; Hatz, C; Steuerwald, M; Veit, O | 1 |
Boatin, BA; Richards, FO | 1 |
Basáñez, MG; Boussinesq, M; Filipe, JA; Gardon, J; Kamgno, J; Pion, SD | 1 |
Boussinesq, M; Geary, T; Mackenzie, C; Prichard, R | 1 |
Boussinesq, M; Kamgno, J; Pion, SD; Tejiokem, MC; Thylefors, B; Twum-Danso, NA | 1 |
Adejai, EO; Adeoye, GO; Akinsanya, B; Atalabi, T; Braide, EI; Ibidapo, CA; Okwuzu, J; Otubanjo, AO | 1 |
Boussinesq, M; Kamgno, J; Labrousse, F; Mackenzie, CD; Nkegoum, B; Thylefors, BI | 1 |
Jacobsen, KH; Padgett, JJ | 1 |
Canton, P; Hulin, C; Kures, L; May, T; Neimann, L; Rabaud, C | 1 |
Cosnefroy, JY; Martin-Prevel, Y; Ngari, P; Pinder, M | 1 |
Debonne, JM; Fourcade, L; Gaxotte, P; Hovette, P; Imbert, P; Laroche, R; Touze, JE | 1 |
Chodakewitz, JA; Cosnefroy, JY; Martin-Prevel, Y; Ngari, P; Pinder, M; Tshipamba, P | 1 |
Boussinesq, M; Chippaux, JP; Ducorps, M; Gardon, J; Gardon-Wendel, N; Ndong, W; Ranque, S; Schneider, D | 1 |
André, PJ | 1 |
Boussinesq, M; Chippaux, JP | 1 |
Burnham, GM | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J | 1 |
Arborio, M; Buisson, Y; Chevalier, B; Cruel, T; Nedelec, G; Neveux, Y; Schill, H; Teyssou, R | 1 |
Boussinesq, M; Gardon, J | 2 |
Duong, TH; Ferrer, A; Gaxotte, P; Kombila, M; Manfoumbi, M; Marion, MC; Nguiri, C; Perret, JL; Richard-Lenoble, D | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Ngoumou, P | 1 |
Chun, SI; Chun, YS; Im, KI; Lee, MG; Moon, TK | 1 |
Chippaux, JP; Ducorps, M; Gardon-Wendel, N; Nkinin, SW | 1 |
Boussinesq, M; Fobi, G; Gardon, J; Gardon-Wendel, N; Ngangue, D; Santiago, M | 1 |
Connor, SJ; Dunne, M; Molyneux, DH; Obsomer, V; Thomson, MC | 1 |
Boussinesq, M; Gardon, J; Kamgno, J | 1 |
Arakaki, N; Higa, F; Ishimine, T; Saito, A; Shinzato, T; Toma, H; Yara, S | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, SD | 1 |
Danis, M; Datry, A; Durepaire, R; Felix, H; Gaxotte, P; Gentilini, M; Paris, L | 1 |
Carme, B; Copin, N; Ebikili, B; Mbitsi, A | 1 |
Toufic, N | 2 |
Noireau, F | 1 |
Chandenier, J; Gaxotte, P; Kombila, M; Richard-Lenoble, D | 1 |
Aziz, MA; Gaxotte, P; Kombila, M; Nguiri, C; Pappayliou, ES; Richard-Lenoble, D; Rupp, EA | 1 |
12 review(s) available for dextrothyroxine and Loa loa Filariasis
Article | Year |
---|---|
Vector control and entomological capacity for onchocerciasis elimination.
Topics: Humans; Ivermectin; Loiasis; Mass Drug Administration; Onchocerciasis | 2022 |
A call for loiasis to be added to the WHO list of neglected tropical diseases.
Topics: Animals; Ivermectin; Loa; Loiasis; Neglected Diseases; Onchocerciasis; World Health Organization | 2022 |
The Brief Case:
Topics: Animals; Humans; Ivermectin; Loa; Loiasis; Nigeria | 2020 |
Loa loa: neglected neurology and nematodes.
Topics: Africa; Animals; Eye; Filaricides; Humans; Ivermectin; Loa; Loiasis; Neglected Diseases; Nervous System Diseases; Parasite Egg Count; Parasite Load; Risk | 2013 |
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Topics: Animals; Anti-Bacterial Agents; Brugia malayi; Child; Doxycycline; Drug Discovery; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Onchocerca volvulus; Onchocerciasis; Pregnancy; Symbiosis; Wolbachia | 2014 |
Loa loa-does it deserve to be neglected?
Topics: Albendazole; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Loiasis | 2014 |
[Loa loa filariasis in Italy: review of the literature with a clinical report].
Topics: Adult; Albendazole; Animals; Antinematodal Agents; Diethylcarbamazine; Diptera; Drug Therapy, Combination; Eosinophilia; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Treatment Outcome | 2011 |
Research for control: the onchocerciasis experience.
Topics: Africa; Animals; Biomedical Research; Cost of Illness; Disease Vectors; Endemic Diseases; Filaricides; Humans; Ivermectin; Loiasis; Models, Biological; Onchocerca; Onchocerciasis; Prevalence | 2004 |
Public-private partnerships in blindness prevention: reaching beyond the eye.
Topics: Blindness; Child; Drug Industry; Elephantiasis, Filarial; Humans; Ivermectin; Loiasis; Malaria; Onchocerciasis, Ocular | 2005 |
Control of onchocerciasis.
Topics: Africa; Americas; Animals; Community Health Services; Drug Resistance; Filaricides; Geography; Humans; Insect Control; Insect Vectors; Ivermectin; Loiasis; National Health Programs; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Simuliidae | 2006 |
Loiasis: African eye worm.
Topics: Africa; Animals; Antiparasitic Agents; Humans; Ivermectin; Life Cycle Stages; Loa; Loiasis; Onchocerciasis, Ocular; Risk Factors | 2008 |
Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
Topics: Adolescent; Adult; Africa, Central; Aged; Animals; Child; Child, Preschool; Contraindications; Endemic Diseases; Filaricides; Humans; Ivermectin; Loiasis; Microfilariae; Middle Aged; Onchocerciasis; Prevalence; Topography, Medical | 1997 |
9 trial(s) available for dextrothyroxine and Loa loa Filariasis
Article | Year |
---|---|
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial.
Topics: Animals; Double-Blind Method; Humans; Ivermectin; Levamisole; Loa; Loiasis; Microfilariae | 2022 |
Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial.
Topics: Adult; Albendazole; Animals; Clinical Protocols; Fishes; Gabon; Humans; Ivermectin; Loiasis | 2023 |
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
Topics: Adult; Aged; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Pilot Projects; Young Adult | 2017 |
Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Europe; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Retrospective Studies; Travel; Tropical Medicine; Young Adult | 2018 |
Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Topics: Adolescent; Adult; Animals; Double-Blind Method; Doxycycline; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Placebos; Treatment Outcome; Young Adult | 2010 |
Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cameroon; Child; Drug Administration Schedule; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Parasitemia; Statistics, Nonparametric | 2002 |
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Topics: Adult; Africa; Animals; Antiparasitic Agents; Double-Blind Method; Female; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerciasis; Treatment Outcome | 2007 |
Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis.
Topics: Adult; Animals; Bilirubin; Drug Tolerance; Eosinophils; Female; Gabon; Humans; Ivermectin; Leukocyte Count; Loa; Loiasis; Male; Microfilariae; Middle Aged | 1993 |
Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia.
Topics: Adolescent; Adult; Aged; Animals; Child; Filaricides; Follow-Up Studies; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Middle Aged; Parasitemia | 1998 |
82 other study(ies) available for dextrothyroxine and Loa loa Filariasis
Article | Year |
---|---|
Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
Topics: Animals; Cameroon; Cross-Sectional Studies; Endemic Diseases; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis; Prevalence | 2022 |
Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Topics: Animals; Antibodies, Helminth; Antiparasitic Agents; Coinfection; Female; Humans; Ivermectin; Loa; Loiasis; Male; Mass Drug Administration; Models, Statistical; Onchocerca; Onchocerciasis | 2022 |
Systemic loiasis diagnosed by direct transconjunctival observation.
Topics: Animals; Diethylcarbamazine; Humans; Ivermectin; Loa; Loiasis | 2023 |
Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
Topics: Animals; Cattle; Filaricides; Gerbillinae; Humans; Ivermectin; Loa; Loiasis; Mice; Microfilariae; Models, Animal; Onchocerciasis | 2023 |
Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
Topics: Animals; Biological Factors; Endemic Diseases; Gabon; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerciasis | 2023 |
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Topics: Adolescent; Adult; Animals; Cameroon; Child; Cohort Studies; Endemic Diseases; Female; Humans; Ivermectin; Loa; Loiasis; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Young Adult | 2020 |
Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Topics: Animals; Anthelmintics; Cameroon; Disease Eradication; Doxycycline; Feasibility Studies; Health Plan Implementation; Humans; Insecticides; Ivermectin; Loiasis; Onchocerca; Onchocerciasis; Patient Acceptance of Health Care; Prevalence; Public Health; Simuliidae; Temefos; World Health Organization | 2019 |
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
Topics: Adolescent; Adult; Africa, Northern; Animals; Black People; Child; Child, Preschool; Communicable Diseases, Imported; Diethylcarbamazine; Female; Humans; Infant; Infant, Newborn; Ivermectin; Loa; Loiasis; Male; Middle Aged; Paris; Prevalence; Retrospective Studies; Treatment Outcome; Tropical Medicine; Young Adult | 2020 |
Loa loa filariasis in a tropical savanna area: report of one case in Ouagadougou.
Topics: Animals; Burkina Faso; Grassland; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Treatment Outcome | 2020 |
Assessing Hypoendemic Onchocerciasis in
Topics: Adult; Antibodies, Helminth; Antiparasitic Agents; Child; Child, Preschool; Disease Eradication; Endemic Diseases; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ivermectin; Local Government; Loiasis; Male; Mass Drug Administration; Middle Aged; Nigeria; Onchocerciasis; Prevalence | 2020 |
Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Topics: Animals; Feasibility Studies; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis; Prevalence | 2021 |
Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
Topics: Animals; Cameroon; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerciasis; Skin | 2021 |
[Long-lasting souvenir from Cameroon - Persistent, massive hypereosinophilia in amicrofilaremic infection with Loa loa].
Topics: Aged; Animals; Anthelmintics; Cameroon; Eosinophilia; Female; Humans; Ivermectin; Loa; Loiasis; Pruritus; Skin; Travel | 2021 |
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Elephantiasis, Filarial; Feces; Female; Helminthiasis; Humans; Ivermectin; Loiasis; Male; Soil; Time Factors | 2017 |
Loiasis, a Subconjunctival Manifestation.
Topics: Albendazole; Animals; Anthelmintics; Child; Conjunctivitis; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Follow-Up Studies; Guinea; Humans; Ivermectin; Loa; Loiasis; Rare Diseases; Treatment Outcome | 2017 |
Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Topics: Animal Structures; Animals; Blood; Blood Chemical Analysis; Disease Models, Animal; Filaricides; Histocytochemistry; Ivermectin; Loa; Loiasis; Papio anubis; Parasite Load | 2017 |
Post-ivermectin encephalopathy in Senegal: a case report.
Topics: Adult; Antiparasitic Agents; Brain Diseases; Humans; Ivermectin; Loiasis; Male; Medication Errors; Senegal | 2017 |
Global programme to eliminate lymphatic filariasis: progress report, 2016.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Global Health; Humans; Ivermectin; Loiasis; Neglected Diseases; Onchocerciasis; Program Evaluation | 2017 |
Absence of
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Child; Child, Preschool; Congo; Female; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Parasite Load; Prevalence; Refugees; Texas; Young Adult | 2017 |
Familial Aggregation and Heritability of Loa loa Microfilaremia.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Cameroon; Coinfection; Female; Genetic Predisposition to Disease; Humans; Ivermectin; Loa; Loiasis; Male; Mansonella; Mansonelliasis; Microfilariae; Middle Aged; Prevalence; Young Adult | 2018 |
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Blood; Cameroon; Child; Elephantiasis, Filarial; Endemic Diseases; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Male; Microfilariae; Microscopy, Video; Middle Aged; Onchocerciasis | 2017 |
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Topics: Africa South of the Sahara; Albendazole; Animals; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Wuchereria bancrofti | 2018 |
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Topics: Africa, Central; Animals; Antiparasitic Agents; Cameroon; Disease Eradication; Elephantiasis, Filarial; Humans; Ivermectin; Loiasis; Onchocerciasis | 2018 |
Diagnosing risk factors alongside mass drug administration using serial diagnostic tests-which test first?
Topics: Algorithms; Animals; Coinfection; Cost-Benefit Analysis; Decision Making; Diagnostic Tests, Routine; Female; Humans; Ivermectin; Loa; Loiasis; Mass Drug Administration; Microfilariae; Onchocerca; Onchocerciasis; Population Health; Pregnancy; Prevalence; Risk Factors | 2018 |
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Child; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Treatment Outcome; Young Adult | 2018 |
Mouse models of Loa loa.
Topics: Animals; Chronic Disease; Disease Models, Animal; Eosinophilia; Female; Inflammation; Ivermectin; Loa; Loiasis; Lymphopenia; Male; Mice, Inbred BALB C; Mice, SCID; Microfilariae; Parasitemia | 2019 |
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Topics: Animals; Cameroon; Costs and Cost Analysis; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis | 2020 |
Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Topics: Africa; Animals; Coinfection; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis | 2020 |
Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy.
Topics: Adolescent; Adult; Aged; Albendazole; Antiprotozoal Agents; Biomarkers; Communicable Diseases, Imported; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Italy; Ivermectin; Loiasis; Male; Middle Aged; Symptom Assessment; Treatment Outcome; Young Adult | 2019 |
Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cameroon; Diptera; Female; Humans; Insecticides; Ivermectin; Larva; Loa; Loiasis; Male; Middle Aged; Onchocerciasis; Parasite Load; Young Adult | 2013 |
Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.
Topics: Adult; Animals; Coinfection; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Malaria; Male; Mansonella; Middle Aged; Multivariate Analysis; Plasmodium falciparum; Risk Factors | 2014 |
Meeting of the International Task Force for Disease Eradication, January 2014.
Topics: Advisory Committees; Africa; Albendazole; Anthelmintics; Disease Eradication; Elephantiasis, Filarial; Endemic Diseases; Humans; Insecticide-Treated Bednets; Ivermectin; Loiasis; Onchocerciasis, Ocular | 2014 |
Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Topics: Animals; Antiparasitic Agents; Brain Diseases; Cameroon; Cell Count; Humans; Ivermectin; Loa; Loiasis; Male; Malondialdehyde; Microfilariae; Papio; Point-of-Care Systems | 2014 |
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Auranofin; Brugia malayi; Cattle; Cell Line; Diethylcarbamazine; Drug Repositioning; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Haplorhini; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2015 |
Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Child, Preschool; Coinfection; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Nigeria; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health; Rainforest; Young Adult | 2015 |
Excess mortality associated with loiasis: a retrospective population-based cohort study.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerciasis; Prevalence; Retrospective Studies | 2017 |
Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Endemic Diseases; Female; Humans; Ivermectin; Loiasis; Male; Middle Aged; National Health Programs; Nigeria; Onchocerciasis; Retrospective Studies; Young Adult | 2008 |
Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
Topics: Adolescent; Adult; Aged; Antinematodal Agents; Cross-Sectional Studies; Female; Humans; Incidence; Ivermectin; Loiasis; Male; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Rural Population; Young Adult | 2008 |
Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
Topics: Anthelmintics; Erythropoietin; Humans; Ivermectin; Loiasis; Neuroprotective Agents | 2010 |
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Topics: Adult; Animals; Anthelmintics; Humans; Ivermectin; Loa; Loiasis; Middle Aged; Periodicity; Young Adult | 2009 |
Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Topics: Animals; Democratic Republic of the Congo; Endemic Diseases; Epidemiologic Methods; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Onchocerca; Onchocerciasis; Prevalence; Time Factors | 2011 |
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Filaricides; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2010 |
[Acute respiratory distress syndrome caused by tropical eosinophilic lung disease: a case in Gabon].
Topics: Adrenal Cortex Hormones; Adult; Animals; Antiparasitic Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Gabon; Humans; Ivermectin; Loa; Loiasis; Oxygen Inhalation Therapy; Pulmonary Eosinophilia; Respiratory Distress Syndrome; Treatment Outcome | 2011 |
Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Female; Filaricides; Geography; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Nigeria; Prevalence; Treatment Outcome; Young Adult | 2011 |
Meeting of the International Task Force for Disease Eradication, April 2011.
Topics: Africa; Antiparasitic Agents; Biomedical Research; Comorbidity; Elephantiasis, Filarial; Endemic Diseases; Humans; Ivermectin; Loiasis; Onchocerciasis; Prevalence | 2011 |
Rapid assessment method for prevalence and intensity of Loa loa infection.
Topics: Adolescent; Adult; Aged; Animals; Cameroon; Endemic Diseases; Filaricides; Humans; Ivermectin; Loa; Loiasis; Mass Screening; Middle Aged; Nigeria; Observation; Onchocerca volvulus; Onchocerciasis; Predictive Value of Tests; Prevalence; Risk Factors; Surveys and Questionnaires | 2002 |
Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Topics: Adolescent; Adult; Aged; Cameroon; Child; Endemic Diseases; Female; Filaricides; Hospitalization; Humans; Ivermectin; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerciasis; Prognosis; Retrospective Studies | 2003 |
[Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
Topics: Adult; Antinematodal Agents; Female; Humans; Ivermectin; Loiasis; Onchocerciasis; Ophthalmoscopy; Retinal Hemorrhage | 2004 |
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Topics: Adolescent; Adult; Age Distribution; Animals; Anthelmintics; Cameroon; Child; Child, Preschool; Disease Reservoirs; Endemic Diseases; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerciasis; Prevalence; Risk Factors; Sex Distribution | 2004 |
Loiasis: the individual factors associated with the presence of microfilaraemia.
Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Animals; Cameroon; Endemic Diseases; Environmental Exposure; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Prevalence; Rural Health; Sex Distribution | 2005 |
What are the mechanisms associated with post-ivermectin serious adverse events?
Topics: Animals; Antiparasitic Agents; Humans; Ivermectin; Loa; Loiasis | 2006 |
First case of ivermectin-induced severe hepatitis.
Topics: Adult; Animals; Antiparasitic Agents; Cameroon; Chemical and Drug Induced Liver Injury; Female; Humans; Ivermectin; Loa; Loiasis; Microfilariae | 2006 |
Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Topics: Adolescent; Adult; Animals; Binomial Distribution; Cameroon; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Likelihood Functions; Loa; Loiasis; Male; Middle Aged; Models, Biological; Onchocerca volvulus; Onchocerciasis; Population Dynamics; Predictive Value of Tests; Prevalence | 2006 |
Where next with Loa loa encephalopathy? Data are badly needed.
Topics: Animals; Antiparasitic Agents; Encephalitis; Humans; Ivermectin; Loa; Loiasis; Microfilariae | 2007 |
Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Topics: Adult; Aged; Animals; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Screening; Middle Aged; Nigeria; Onchocerciasis; Prevalence | 2008 |
Lymphatic filariasis.
Topics: Adult; Antiparasitic Agents; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Onchocerciasis, Ocular; Pregnancy | 2008 |
Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Topics: Animals; Antiparasitic Agents; Brain Diseases; Cameroon; Fatal Outcome; Humans; Ivermectin; Loa; Loiasis; Malaria; Male; Middle Aged; Plasmodium | 2008 |
[Pulmonary involvement with a favorable course during Loa loa filariasis].
Topics: Cameroon; Diethylcarbamazine; Humans; Ivermectin; Loiasis; Lung Diseases, Parasitic; Male; Middle Aged; Radiography | 1994 |
Reduction of microfilaraemia with single high-dose of ivermectin in loiasis.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Middle Aged | 1993 |
Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias.
Topics: Adult; Animals; Humans; Ivermectin; Loiasis; Microfilariae | 1994 |
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Topics: Adult; Aged; Animals; Arthralgia; C-Reactive Protein; Cameroon; Diethylcarbamazine; Female; Fever; Filaricides; Headache; Hematuria; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Onchocerciasis; Parasitemia; Proteinuria; Pruritus | 1995 |
[Ivermectin and loiasis: a Central African experience].
Topics: Central African Republic; Drug Monitoring; Filaricides; Humans; Ivermectin; Loiasis | 1996 |
[Severe secondary reactions related to ivermectin treatment in patients with loiasis].
Topics: Antinematodal Agents; Coma; Humans; Ivermectin; Loiasis; Patient Selection; Prevalence | 1996 |
Ivermectin where Loa loa is endemic.
Topics: Africa; Anthelmintics; Endemic Diseases; Humans; Ivermectin; Loiasis | 1997 |
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Antinematodal Agents; Endemic Diseases; Female; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerca volvulus; Onchocerciasis; Risk Factors | 1997 |
[Nephropathy and filariasis from Loa loa. Apropos of 1 case of adverse reaction to a dose of ivermectin].
Topics: Adult; Animals; Antigens, Helminth; Basement Membrane; Complement C3; Filaricides; Humans; Immunoglobulin M; Ivermectin; Kidney; Kidney Diseases; Loiasis; Male; Microscopy, Electron | 1997 |
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Brain Diseases; Cerebrospinal Fluid; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Onchocerciasis | 1998 |
A case of loiasis.
Topics: Adult; Angioedema; Animals; Antinematodal Agents; Arm; Enzyme-Linked Immunosorbent Assay; Humans; Ivermectin; Loa; Loiasis; Male; Skin Diseases | 1998 |
[Release of Loa loa antigens after treatment with ivermectin].
Topics: Animals; Antigens, Helminth; Filaricides; Humans; Ivermectin; Loa; Loiasis | 1998 |
Challenges for the future: loiasis.
Topics: Encephalitis; Filaricides; Forecasting; Humans; Ivermectin; Loiasis; Program Evaluation | 1998 |
Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Conjunctival Diseases; Eye Hemorrhage; Female; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Parasitemia; Retinal Hemorrhage; Risk Factors; Treatment Outcome | 2000 |
Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Topics: Africa; Animals; Antinematodal Agents; Endemic Diseases; Female; Geography; Humans; Ivermectin; Loa; Loiasis; Onchocerca volvulus; Onchocerciasis; Prevalence | 2000 |
[Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
Topics: Adult; Aged; Animals; Anthelmintics; Brain Diseases; Cameroon; Humans; Intracranial Embolism; Ivermectin; Loa; Loiasis; Microfilariae; Middle Aged; Onchocerciasis; Parasitemia | 2000 |
[A case of loiasis].
Topics: Adult; Antinematodal Agents; Gabon; Humans; Ivermectin; Loiasis; Male; Treatment Outcome | 2001 |
Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Topics: Adolescent; Adult; Aged; Animals; Cameroon; Child; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Neurotoxicity Syndromes; Onchocerciasis; Predictive Value of Tests; Prevalence; Sensitivity and Specificity | 2001 |
[Value of ivermectin in the initial treatment of loaiasis].
Topics: Diethylcarbamazine; Female; Humans; Ivermectin; Loiasis; Male | 1991 |
[Therapeutic trial with ivermectin in loiasis with medium and high microfilaremia].
Topics: Animals; Dose-Response Relationship, Drug; Humans; Ivermectin; Loiasis; Microfilariae | 1991 |
[A new microfilaricide in the therapeutic arsenal of the ophthalmologist].
Topics: Blindness; Filariasis; Humans; Ivermectin; Loiasis; Onchocerciasis | 1990 |
[Current possibilities in the control of Loa Loa filariasis].
Topics: Animals; Diethylcarbamazine; Diptera; Ecology; Humans; Insect Control; Ivermectin; Loa; Loiasis | 1990 |
[The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Topics: Filariasis; Humans; Ivermectin; Loiasis; Mansonelliasis; Onchocerciasis | 1989 |
Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Topics: Adult; Aged; Animals; Filariasis; Humans; Ivermectin; Loa; Loiasis; Male; Mansonella; Mansonelliasis; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis | 1988 |
[Loaiasis and its therapeutic difficulties].
Topics: Diethylcarbamazine; Eye Diseases; Filariasis; Humans; Ivermectin; Loiasis | 1986 |